Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis

Objective/Background: Among patients undergoing allogeneic hematopoietic cell transplant, continuous intravenous (IV) tacrolimus infusion is frequently used for graft-versus-host disease (GvHD) prophylaxis. Twice-daily intermittent IV tacrolimus dosing may confer safety and convenience benefits. Met...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Hamza Hashmi, Shruti Bhandari, Rohit Kumar, Prashant Tripathi, Jill Blancett Rhodes, Lindsay Figg, Timothy Baize, Maxwell M. Krem, Mohamed Hegazi, Robert Emmons
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wolters Kluwer Medknow Publications 2020-10-01
Reeks:	Hematology/Oncology and Stem Cell Therapy
Onderwerpen:	allogeneic hematopoietic cell transplant tacrolimus graft-versus-host disease
Online toegang:	https://journals.lww.com/10.1016/j.hemonc.2020.03.002
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!